Jun Yashima
Kameda, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Impact of Dynapenia on Short-Term Changes in Handgrip Strength Among Japanese Kidney Transplant Recipients: A Cross-Sectional Study.
Journal: Clinical transplantation
Published: February 20, 2025
Impact of ABO Compatibility/Incompatibility on the Perioperative Anti-SARS-CoV-2 Immunoglobulin G Levels in 2 Preoperatively Vaccinated Patients Undergoing Kidney Transplant: A Case Report.
Journal: Transplantation proceedings
Published: August 15, 2022
Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination.
Journal: Clinical and experimental nephrology
Published: July 11, 2022
Evaluation of the Correlation Between Responders and Non-Responders to the Second Coronavirus Disease Vaccination In Kidney Transplant Recipients: A Retrospective Single-Center Cohort Study.
Journal: Transplantation proceedings
Published: April 24, 2022
Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease.
Journal: Renal replacement therapy
Published: January 14, 2022
Successful cadaveric kidney transplantation in an extended-hours hemodialysis patient with long-term hemodialysis vintage for 297 months.
Journal: Urology case reports
Published: January 18, 2020
Early Steroid Withdrawal Protocol With Basiliximab and Rituximab in ABO-Incompatible Kidney Transplant Recipients.
Journal: Transplantation proceedings
Published: November 08, 2019
Low-dose In Situ Perfusion With Euro-Collins Solution Is Effective for the Procurement of Marginal Kidney Grafts From Donation After Circulatory Death Donors.
Journal: Transplantation proceedings
Published: November 05, 2018
Thrombotic microangiopathy caused by oral contraceptives in a kidney transplant recipient.
Journal: Nephrology (Carlton, Vic.)
Published: March 04, 2016
Efficacy and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in kidney transplant recipients.
Journal: Transplantation proceedings
Published: September 14, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026